Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

FDA clearance for clinical surveillance solution

March 16, 2022 Research and Development

The latest Philips Capsule Surveillance solution has received market clearance from the FDA, paving the way for widespread deployment across …
News

Vicore adds to rare lung disease pipeline with PAH indication

March 9, 2022 Research and Development

Vicore Pharma has announced plans to initiate a clinical trial with C21 in pulmonary arterial hypertension (PAH).
News

NICE draft guidance does not recommend pembrolizumab plus chemo for triple negative breast cancer

March 9, 2022 Research and Development

Draft guidance published by NICE for public consultation does not recommend pembrolizumab in combination with chemotherapy (paclitaxel or nab-paclitaxel) for …
News

Omicron sub-variant BA.2 makes up 11.6% of COVID-19 variants in US

March 9, 2022 Research and Development

The CDC said that the BA.2 sub-variant of Omicron is estimated to be 11.6% of the coronavirus variants circulating in …
News

MHRA authorisation of new treatment for chronic kidney disease associated with diabetes

March 9, 2022 Research and Development

The MHRA has authorised the use of Kerendia® (finerenone) (10mg or 20mg), an oral, first-in-class non-steroidal, selective mineralocorticoid receptor (MR) …
News

First smart connected insulin pens made available on NHS

March 2, 2022 Research and Development

Today, Novo Nordisk will launch the first smart connected insulin pens to be made available on NHS prescription. The pens, …
News

Fera Pharmaceuticals receives Orphan Drug Designation from FDA for sickle cell treatment

March 2, 2022 Research and Development

The FDA has granted an Orphan Drug Designation for naproxcinod for the treatment of sickle cell disease, which affects an …
News

HPV vaccines could mean only one smear test a lifetime

March 2, 2022 Research and Development

A leading scientist has said that women who have the HPV vaccine may need only one smear test to prevent …
News

FDA share new trial guidelines to further cancer therapy development

March 2, 2022 Research and Development

The FDA has issued three recommendations to industry for clinical trials, to support US President Joe Biden’s relaunch of the …
News

93% accuracy in new Alzheimer’s test, according to international study

February 23, 2022 Research and Development

The Washington University School of Medicine in St Louis has developed a blood test for Alzheimer’s disease which has proved …
News

Extra blood test could help detect risk of death from heart attack

February 23, 2022 Research and Development

Researchers say that an extra blood test on suspected heart-attack patients could determine if they are at high risk of …
News

FDA places gene therapy trial on hold

February 23, 2022 Research and Development

Homology Medicines has shared that the FDA has placed its pheNIX gene therapy trial of HMI-102 in adults with phenylketonuria …
News

NICE recommends Albireo’s Bylvay (odevixibat) for all PFIC types

February 23, 2022 Research and Development

NICE has issued guidance that recommends Bylvay (odevixibat) for the treatment of all types of progressive familial intrahepatic cholestasis (PFIC) …
News

Invitae launches first CE-IVD cancer testing kits in Europe

February 16, 2022 Research and Development

Invitae, leading medical genetics company, announced the availability of FusionPlex Dx and LiquidPlex Dx in Europe.With this development, the company …
News

AstraZeneca COVID-19 vaccine’s short shelf life inhibits rollout to poor countries

February 16, 2022 Research and Development

According to officials and WHO documents, the short shelf life of the AstraZeneca COVID-19 vaccine is complicating the rollout to …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026